FDA's Office of Orphan Products Development has awarded Celtrix Pharmaceuticals Inc. $600,000 to support Phase III trials of BetaKine for treatment of macular holes
Robert Whitehead, former president and general manager of Searle Canada and senior vice president of Solvay Pharmaceuticals, has been named president, chief executive officer and a director of Houghten Pharmaceuticals Inc...Skaletsky is the president and chief executive officer of GelTex Pharmaceuticals Inc
That's what he and his laboratory at the University of Massachusetts Program in Molecular Medicine are now doing, in collaboration with a spin-off biotechnology company, ScripTech Pharmaceuticals Inc
On Oct. 8, Amylin Pharmaceuticals Inc. (NASDAQ:AMLN) completed its follow-on offering, selling all 2 million shares at $11 each in about 10 days...And Incyte Pharmaceuticals Inc
Magainin Pharmaceuticals Inc.'s broad-spectrum anti-infective drug MSI-78 was able to reduce the number of bacteria and fungi present in a skin infection by three to four orders of magnitude within one hour, according to results presented on Monday at the 33rd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in New Orleans
BOSTON -- Monday was a double-header day for Interneuron Pharmaceuticals Inc., which reported key events for its two lead products, both dietary supplements
John Young, retired president and chief executive officer of Hewlett-Packard Co., has joined the board of directors of Shaman Pharmaceuticals Inc...Axion Pharmaceuticals Inc
David Larocca, director of molecular biology at Hygeia Pharmaceuticals Inc., today described progress made in decoding the DNA structure of an antigen present on the surface and within the cytoplasm of certain cancers
Telios Pharmaceuticals Inc.'s Argidene Gel reduced the surface size of leg ulcers in patients with sickle cell anemia but did not completely heal the ulcers, according to results of a randomized, placebo-controlled study of 55 patients treated once a week for up to 10 weeks
16 and completed the offering Oct. 19. -- Amylin Pharmaceuticals Inc...Incyte Pharmaceuticals Inc., which filed for an IPO Oct. 11